Your browser doesn't support javascript.
loading
Association of tumour burden with the efficacy of programmed cell death-1/programmed cell death ligand-1 inhibitors for treatment-naïve advanced non-small-cell lung cancer.
Suzuki, Shinichiro; Haratani, Koji; Hayashi, Hidetoshi; Chiba, Yasutaka; Tanizaki, Junko; Kato, Ryoji; Mitani, Seiichiro; Kawanaka, Yusuke; Kurosaki, Takashi; Hasegawa, Yoshikazu; Okabe, Takafumi; Tanaka, Kaoru; Akashi, Yusaku; Ozaki, Tomohiro; Nishio, Kazuto; Ito, Akihiko; Nakagawa, Kazuhiko.
Afiliação
  • Suzuki S; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan. Electronic address: s.suzuki-oncologist@med.kindai.ac.jp.
  • Haratani K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan. Electronic address: haratani_k@med.kindai.ac.jp.
  • Hayashi H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan. Electronic address: hidet31@med.kindai.ac.jp.
  • Chiba Y; Clinical Research Center, Kindai University Hospital, Osaka-Sayama, Osaka 589-8511, Japan. Electronic address: chibay@med.kindai.ac.jp.
  • Tanizaki J; Department of Medical Oncology, Kishiwada City Hospital, Kishiwada, Osaka 596-8501, Japan. Electronic address: tanizaki_j@med.kindai.ac.jp.
  • Kato R; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan. Electronic address: kato.r@med.kindai.ac.jp.
  • Mitani S; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan. Electronic address: seiichiro.mitani@med.kindai.ac.jp.
  • Kawanaka Y; Department of Medical Oncology, Kishiwada City Hospital, Kishiwada, Osaka 596-8501, Japan. Electronic address: yusuke-kawanaka@med.kindai.ac.jp.
  • Kurosaki T; Department of Medical Oncology, Izumi City General Hospital, Izumi, Osaka 594-0073, Japan. Electronic address: kurosaki_t@med.kindai.ac.jp.
  • Hasegawa Y; Department of Medical Oncology, Izumi City General Hospital, Izumi, Osaka 594-0073, Japan. Electronic address: yoshikazuhasegawa@hotmail.co.jp.
  • Okabe T; Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Nara 630-0293, Japan. Electronic address: tokabe@med.kindai.ac.jp.
  • Tanaka K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan. Electronic address: katanaka@med.kindai.ac.jp.
  • Akashi Y; Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Nara 630-0293, Japan. Electronic address: y-akashi@med.kindai.ac.jp.
  • Ozaki T; Department of Medical Oncology, Kishiwada City Hospital, Kishiwada, Osaka 596-8501, Japan. Electronic address: ozakit2016@gmail.com.
  • Nishio K; Department of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan. Electronic address: knishio@med.kindai.ac.jp.
  • Ito A; Department of Pathology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan. Electronic address: aito@med.kindai.ac.jp.
  • Nakagawa K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan. Electronic address: nakagawa@med.kindai.ac.jp.
Eur J Cancer ; 161: 44-54, 2022 01.
Article em En | MEDLINE | ID: mdl-34922263
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antígeno B7-H1 / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antígeno B7-H1 / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article